These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1878736)

  • 1. Serum erythropoietin levels in allogeneic, non T-depleted bone marrow transplantation, and the effects of rhEpo administration.
    Bosi A; Vannucchi AM; Grossi A; Guidi S; Rafanelli D; Saccardi R; Ferrini PR
    Bone Marrow Transplant; 1991; 7 Suppl 2():87. PubMed ID: 1878736
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants.
    Locatelli F; Zecca M; Pedrazzoli P; Prete L; Quaglini S; Comoli P; De Stefano P; Beguin Y; Robustelli della Cuna G; Severi F
    Bone Marrow Transplant; 1994 Apr; 13(4):403-10. PubMed ID: 8019464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin for long-term persistent anemia after major ABO-incompatible bone marrow transplantation.
    Taniguchi S; Yamasaki K; Shibuya T; Asayama R; Harada M; Niho Y
    Bone Marrow Transplant; 1993 Oct; 12(4):423. PubMed ID: 8275046
    [No Abstract]   [Full Text] [Related]  

  • 4. High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study.
    Vannucchi AM; Bosi A; Linari S; Guidi S; Longo G; Lombardini L; Mariani MP; Saccardi R; Laszlo D; Rossi Ferrini P
    Haematologica; 1997; 82(1):53-6. PubMed ID: 9107083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced blood transfusions requirements after allogeneic bone marrow transplantation: results of a randomised, double-blind study with high-dose erythropoietin.
    Klaesson S; Ringdén O; Ljungman P; Lönnqvist B; Wennberg L
    Bone Marrow Transplant; 1994 Apr; 13(4):397-402. PubMed ID: 8019463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot trial of combined administration of erythropoietin and granulocyte colony-stimulating factor to children undergoing allogeneic bone marrow transplantation.
    Locatelli F; Zecca M; Ponchio L; Beguin Y; Giorgiani G; Maccario R; Bonetti F; De Stefano P; Cazzola M
    Bone Marrow Transplant; 1994 Dec; 14(6):929-35. PubMed ID: 7536073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin after bone marrow transplantation.
    Miller CB; Mills S
    Hematol Oncol Clin North Am; 1994 Oct; 8(5):975-92. PubMed ID: 7852219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inadequate erythropoietin production in allogeneic bone marrow transplant patients.
    Bosi A; Vannucchi AM; Grossi A; Guidi S; Saccardi R; Rafanelli D; Longo G; Ferrini PR
    Haematologica; 1991; 76(4):280-4. PubMed ID: 1794734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial.
    Vannucchi AM; Bosi A; Ieri A; Guidi S; Saccardi R; Lombardini L; Linari S; Laszlo D; Longo G; Rossi-Ferrini P
    Bone Marrow Transplant; 1996 Apr; 17(4):527-31. PubMed ID: 8722349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of erythropoietin in the treatment of post-bone marrow transplantation anemia.
    Vannucchi AM; Bosi A; Grossi A; Guidi S; Saccardi R; Bacci P; Lombardini L; Rossi-Ferrini P
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():8-12. PubMed ID: 8014003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation.
    Locatelli F; Pedrazzoli P; Barosi G; Zecca M; Porta F; Liberato L; Gambarana D; Nespoli L; Cazzola M
    Br J Haematol; 1992 Apr; 80(4):545-9. PubMed ID: 1581240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
    Marques da Costa R
    Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recombinant human erythropoietin and interleukin-3 on erythropoietic recovery from acute anemia.
    Rosen BS; Levine EA; Egrie JC; Sehgal LR; Greenberg R; Rosen AL; Levine HD; Gould SA
    Exp Hematol; 1993 Oct; 21(11):1487-91. PubMed ID: 8405228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose erythropoietin is effective in reducing transfusion requirements following allogeneic HSCT.
    Fox CP; Pacey S; Das-Gupta EP; Russell NH; Byrne JL
    Transfus Med; 2005 Dec; 15(6):475-80. PubMed ID: 16359418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human erythropoietin for late-onset anemia after allogeneic bone marrow transplantation.
    Fujimori Y; Kanamaru A; Saheki K; Mori A; Takatsuka H; Wada H; Okada M; Tamura S; Okamoto T; Takemoto Y; Kakishita E; Nagai K
    Int J Hematol; 1998 Feb; 67(2):131-6. PubMed ID: 9631579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with erythropoietin after allogeneic bone marrow transplantation: a randomized, double-blind study.
    Klaesson S; Ringdén O; Ljungman P; Lönnqvist B; Wennberg L
    Transplant Proc; 1994 Jun; 26(3):1827-8. PubMed ID: 8030158
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of anemia in myelodysplastic syndromes with recombinant human erythropoietin].
    Rodríguez JN; Prados D; Martino ML; Muñiz R
    Sangre (Barc); 1993 Aug; 38(4):340-1. PubMed ID: 8235952
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of renal anemia with recombinant human erythropoietin].
    Burghard R; Gordjani N; Leititis JU
    Monatsschr Kinderheilkd; 1989 Mar; 137(3):174-7. PubMed ID: 2716749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) reduces infection-related mortality after allogeneic T-cell depleted BMT.
    De Witte T; Gratwohl A; Van der Lely N; Bacigalupo A; Stern AC; Speck B; Schattenberg A; Nissen C; Gluckman E; Fibbe WE
    Bone Marrow Transplant; 1991; 7 Suppl 2():83. PubMed ID: 1908729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.